FY2019 Earnings Forecast for CRH Medical Corp (CRH) Issued By Clarus Securities

CRH Medical logo CRH Medical Corp (TSE:CRH) – Research analysts at Clarus Securities reduced their FY2019 EPS estimates for CRH Medical in a research note issued to investors on Wednesday, March 20th. Clarus Securities analyst N. Atkinson now expects that the company will post earnings of $0.01 per share for the year, down from their prior estimate of $0.09. Clarus Securities currently has a “Buy” rating on the stock. Clarus Securities also issued estimates for CRH Medical’s FY2020 earnings at $0.09 EPS.

Several other research analysts have also recently issued reports on the company. TD Securities dropped their price objective on CRH Medical from C$6.50 to C$5.50 and set a “buy” rating on the stock in a research note on Wednesday, January 9th. Acumen Capital dropped their price objective on CRH Medical from C$6.25 to C$6.00 in a research note on Friday, March 15th.

Shares of TSE:CRH opened at C$3.50 on Friday. CRH Medical has a 52-week low of C$3.09 and a 52-week high of C$5.91. The company has a market capitalization of $250.99 million and a P/E ratio of 55.56. The company has a current ratio of 2.56, a quick ratio of 2.46 and a debt-to-equity ratio of 50.94.

CRH Medical (TSE:CRH) last released its earnings results on Wednesday, March 13th. The company reported C$0.03 EPS for the quarter, meeting analysts’ consensus estimates of C$0.03. The business had revenue of C$42.33 million for the quarter, compared to the consensus estimate of C$41.45 million.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O’Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Read More: How a Back-End Load Mutual Fund Works Earnings History and Estimates for CRH Medical (TSE:CRH) Receive News & Ratings for CRH Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CRH Medical and related companies with MarketBeat.com’s FREE daily email newsletter .

Click Here to Continue...